Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bellring Brands (BRBR) Other Accumulated Expenses (2019 - 2025)

Bellring Brands' Other Accumulated Expenses history spans 7 years, with the latest figure at $173.4 million for Q4 2025.

  • For Q4 2025, Other Accumulated Expenses rose 108.92% year-over-year to $173.4 million; the TTM value through Dec 2025 reached $173.4 million, up 108.92%, while the annual FY2025 figure was $163.3 million, 97.46% up from the prior year.
  • Other Accumulated Expenses for Q4 2025 was $173.4 million at Bellring Brands, up from $163.3 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $173.4 million in Q4 2025 and bottomed at $35.0 million in Q1 2021.
  • The 5-year median for Other Accumulated Expenses is $66.1 million (2023), against an average of $76.8 million.
  • The largest annual shift saw Other Accumulated Expenses fell 4.11% in 2021 before it surged 108.92% in 2025.
  • A 5-year view of Other Accumulated Expenses shows it stood at $38.2 million in 2021, then soared by 43.19% to $54.7 million in 2022, then surged by 30.16% to $71.2 million in 2023, then increased by 16.57% to $83.0 million in 2024, then soared by 108.92% to $173.4 million in 2025.
  • Per Business Quant, the three most recent readings for BRBR's Other Accumulated Expenses are $173.4 million (Q4 2025), $163.3 million (Q3 2025), and $164.4 million (Q2 2025).